Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Anifrolumab in SLE Extension Study
NCT01753193Phase 2Completed
- Sponsor
- MedImmune
- Start
- Mar 2013
- Primary completion
- Jul 2018
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of anifrolumab in systemic lupus erythematosus (SLE), sponsored by MedImmune. Started Mar 2013; status: completed.
02
Drugs
anifrolumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01753193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753193.